Competitive Dynamics and Strategic Developments in the Localized Scleroderma Market
The Localized Scleroderma Market was valued at USD 0.5 billion in 2024 and is projected to reach USD 1.2 billion by 2034, registering a CAGR of 8.5%. This growth trajectory is underpinned by several factors, including the rising prevalence of localized scleroderma, increasing awareness of the disease, and advancements in treatment options. The demand for effective therapies is further amplified...
0 Комментарии 0 Поделились 368 Просмотры 0 предпросмотр